🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00509G209
- Market Cap
- Small Cap
- IPO
- 7/1/2021 · $16.00/share
Business: Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (AβOs), which Acumen believes to be a key underlying cause of Alzheimer’s disease
Company Contact
- CEO
- J. Bryan Kitchen
- CFO
- Ryan Kavalauskas
- Headquarters
- 1210-1220 Washington St., Suite 210, Newton, MA 02465
- Phone
- 617-344-4190
- Investor Relations
- investors@acumenpharm.com